Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)

SHA:688506 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 15, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	130,121	76,884	56,100	-	-	-
Market Cap Growth	62.65%	37.05%	-	-	-	-
Enterprise Value	127,735	73,458	56,019	-	-	-
Last Close Price	315.16	191.73	139.90	-	-	-
PE Ratio	-	20.74	-	-	-	-
Forward PE	-	71.91	-	-	-	-
PS Ratio	58.45	13.20	99.85	-	-	-
PB Ratio	18.15	19.79	369.39	-	-	-
P/TBV Ratio	18.22	19.92	452.87	-	-	-
P/FCF Ratio	-	19.34	-	-	-	-
P/OCF Ratio	-	18.94	-	-	-	-
EV/Sales Ratio	57.38	12.62	99.70	-	-	-
EV/EBITDA Ratio	-	19.57	-	-	-	-
EV/EBIT Ratio	-	19.93	-	-	-	-
EV/FCF Ratio	-50.14	18.48	-	-	-	-
Debt / Equity Ratio	0.53	0.53	4.53	0.59	0.87	0.33
Debt / EBITDA Ratio	-	0.55	-	-	-	5.68
Debt / FCF Ratio	-	0.52	-	-	-	2.38
Asset Turnover	0.23	1.36	0.33	0.48	0.80	0.95
Inventory Turnover	1.50	1.87	2.00	2.59	2.75	2.82
Quick Ratio	3.77	2.99	0.52	1.73	0.62	0.89
Current Ratio	5.31	3.19	0.74	1.94	0.90	1.07
Return on Equity (ROE)	-14.94%	183.64%	-143.77%	-44.62%	-25.51%	8.62%
Return on Assets (ROA)	-5.41%	53.82%	-28.74%	-14.01%	-10.00%	-1.34%
Return on Capital (ROIC)	-6.23%	67.82%	-42.30%	-19.63%	-16.33%	-2.33%
Return on Capital Employed (ROCE)	-8.20%	71.50%	-211.60%	-26.30%	-33.20%	-4.50%
Earnings Yield	-0.66%	4.82%	-1.39%	-	-	-
FCF Yield	-1.96%	5.17%	-1.24%	-	-	-
Payout Ratio	-	1.03%	-	-	-	26.28%
Buyback Yield / Dilution	-0.63%	-0.14%	-10.56%	-1.38%	-3.64%	10.86%
Total Shareholder Return	-0.63%	-0.14%	-10.56%	-1.38%	-3.64%	10.86%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.